Adam Torkildson – Lifestyle
Author:
BOSTON SCIENTIFIC CORPORATION
Boston Scientific announces results for first quarter 2026
April 22, 2026
Boston Scientific announces conference call discussing first quarter 2026 results
March 30, 2026
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
March 28, 2026
HI-PEITHO trial demonstrates Boston Scientific EKOS™ Endovascular System is superior to standard of care for treatment of acute pulmonary embolism
March 28, 2026